Table 5 Characteristics of patients with liver injury among current users of
non-steroidal anti-inflammatory drugs (NSAIDs). Values are numbers
(percentages) of patients unless stated otherwise
|
Characteristic
|
Nimesulide (n=16)
|
Other NSAIDs (n=20)
|
Median age
|
79
|
69
|
Male to female ratio
|
7:9
|
9:11
|
Other drugs (30 days before admission)
|
14 (87)
|
15 (75)
|
Median ratio*
|
|
|
Alanine aminotransferase
|
4.4
|
5.1
|
Median alkaline phosphatase
|
2.8
|
1.6
|
Dechallenge
(positive)
|
12 (75)
|
13 (65)
|
Dechallenge (inconclusive)
|
4 (25)
|
7 (35)
|
Rechallenge
|
8 (50)
|
5 (25)
|
Deaths
|
1 (6)
|
2 (8)
|
|
Three patients who received both nimesulide and other NSAIDs during the
current period (mixed use) are counted in both groups. In six patients the
liver injury was hepatocellular, in 13 it was cholestatic, and in 14 it was
mixed.6
* Ratio between maximum value and upper normal limits.
Normalisation of liver function before discharge.